Human OCIAD2 (Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2) ELISA Kit

Test Principle:
The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2(OCIAD2). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2(OCIAD2). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2(OCIAD2), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Ovarian Cancer Immuno Reactive Antigen Domain Containing Protein 2(OCIAD2) in the samples is then determined by comparing the OD of the samples to the standard curve.

Research Area: Tumor immunity

Alternative Names:
OCIA Domain Containing 2, Ovarian carcinoma immunoreactive antigen-like protein

Sample Type:
Tissue homogenates, cell lysates and other biological fluids.

Assay Type: Sandwich

Standard: 20 ng/mL

Assay Length: 4.5h

Assay Length: For Research Use Only